Details for Patent: 7,018,992
✉ Email this page to a colleague
Summary for Patent: 7,018,992
Title: | Hormone composition |
Abstract: | Twice weekly administration of an analog to a Vagifem tablet which only contains 10 .mu.g of active material has a sufficient effect. |
Inventor(s): | Koch; Karen (Charlottenlund, DK), Kvorning; Ingelise (Bronshoj, DK) |
Assignee: | Novo Nordisk A/S (Bagsvaerd, DK) |
Application Number: | 10/016,858 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 7,018,992 |
Patent Claim Types: see list of patent claims | Use; Dosage form; |
Drugs Protected by US Patent 7,018,992
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 7,018,992
Foriegn Application Priority Data | ||
Foreign Country | Foreign Patent Number | Foreign Patent Date |
Denmark | 2000 01891 | Dec 15, 2000 |
Denmark | 2000 01892 | Dec 15, 2000 |
Denmark | 2000 01890 | Dec 15, 2000 |
International Family Members for US Patent 7,018,992
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 532521 | ⤷ Sign Up | |||
Australia | 2156702 | ⤷ Sign Up | |||
Cyprus | 1112542 | ⤷ Sign Up | |||
Germany | 10179223 | ⤷ Sign Up | |||
Germany | 20120246 | ⤷ Sign Up | |||
Denmark | 1343508 | ⤷ Sign Up | |||
Denmark | 2366395 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |